What changed
Kevin Sayer, former CEO of Dexcom from 2015 to 2026 and current Executive Chairman of its board, joined Guardant Health's board of directors. Sayer served as Dexcom's Chairman since 2018 and as a director since 2007, and previously was CFO of Biosensors International Group and MiniMed. The appointment adds digital health and operational leadership to Guardant's board as the company pursues liquid biopsy growth in screening, monitoring, and treatment selection.
Why it matters
Kevin Sayer, former CEO of Dexcom from 2015 to 2026 and current Executive Chairman of its board, joined Guardant Health's board of directors. Sayer served as Dexcom's Chairman since 2018 and as a dire
← Dashboard
Nov 04, 2026 04:54 PM ET